Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyoderma Gangrenosum | 3 | 2021 | 19 | 1.580 |
Why?
|
| Dermatitis, Atopic | 3 | 2023 | 56 | 1.050 |
Why?
|
| Pruritus | 4 | 2021 | 29 | 1.000 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2024 | 22 | 0.940 |
Why?
|
| Granuloma, Giant Cell | 1 | 2024 | 5 | 0.930 |
Why?
|
| Urticaria | 1 | 2024 | 14 | 0.910 |
Why?
|
| Arthralgia | 1 | 2024 | 40 | 0.890 |
Why?
|
| Fever | 1 | 2024 | 128 | 0.850 |
Why?
|
| Dermatologic Agents | 1 | 2023 | 73 | 0.830 |
Why?
|
| Carcinoma, Lobular | 1 | 2023 | 81 | 0.820 |
Why?
|
| Cost of Illness | 1 | 2019 | 149 | 0.620 |
Why?
|
| Liver Transplantation | 1 | 2024 | 1178 | 0.550 |
Why?
|
| Immunosenescence | 1 | 2016 | 4 | 0.530 |
Why?
|
| Th2 Cells | 1 | 2016 | 147 | 0.490 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 599 | 0.460 |
Why?
|
| Exanthema | 2 | 2024 | 40 | 0.390 |
Why?
|
| Skin Diseases | 2 | 2024 | 174 | 0.330 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 3019 | 0.330 |
Why?
|
| Skin Neoplasms | 2 | 2024 | 600 | 0.290 |
Why?
|
| Administration, Cutaneous | 2 | 2023 | 60 | 0.260 |
Why?
|
| Prevalence | 2 | 2021 | 1251 | 0.260 |
Why?
|
| Humans | 14 | 2024 | 90539 | 0.240 |
Why?
|
| Skin | 3 | 2023 | 590 | 0.240 |
Why?
|
| Nail Diseases | 1 | 2024 | 6 | 0.240 |
Why?
|
| Male | 8 | 2024 | 42909 | 0.230 |
Why?
|
| Administration, Topical | 1 | 2023 | 95 | 0.220 |
Why?
|
| Calcineurin Inhibitors | 1 | 2023 | 53 | 0.220 |
Why?
|
| Female | 7 | 2024 | 46831 | 0.200 |
Why?
|
| Middle Aged | 4 | 2024 | 26305 | 0.200 |
Why?
|
| TRPV Cation Channels | 2 | 2021 | 16 | 0.190 |
Why?
|
| Hutchinson's Melanotic Freckle | 1 | 2021 | 4 | 0.190 |
Why?
|
| Basophils | 1 | 2021 | 26 | 0.180 |
Why?
|
| Mucositis | 1 | 2020 | 17 | 0.180 |
Why?
|
| Infliximab | 1 | 2021 | 159 | 0.180 |
Why?
|
| Aged | 4 | 2024 | 19380 | 0.170 |
Why?
|
| Chronic Disease | 3 | 2021 | 959 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1607 | 0.170 |
Why?
|
| Sex Distribution | 1 | 2019 | 170 | 0.160 |
Why?
|
| Age Distribution | 1 | 2019 | 198 | 0.160 |
Why?
|
| Bias | 1 | 2019 | 135 | 0.160 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2017 | 7 | 0.150 |
Why?
|
| Dermis | 1 | 2017 | 28 | 0.140 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 37 | 0.140 |
Why?
|
| Keratinocytes | 1 | 2017 | 146 | 0.130 |
Why?
|
| Antipruritics | 1 | 2016 | 3 | 0.130 |
Why?
|
| Sampling Studies | 1 | 2016 | 73 | 0.130 |
Why?
|
| Sex Factors | 1 | 2019 | 1074 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 233 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2019 | 355 | 0.120 |
Why?
|
| Age Factors | 1 | 2019 | 1871 | 0.120 |
Why?
|
| Macrophages | 1 | 2017 | 585 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 1061 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1735 | 0.110 |
Why?
|
| Adult | 2 | 2024 | 26922 | 0.100 |
Why?
|
| Neurons | 1 | 2021 | 1593 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2023 | 9310 | 0.100 |
Why?
|
| Genome | 1 | 2015 | 393 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1805 | 0.100 |
Why?
|
| Drosophila | 1 | 2015 | 522 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2021 | 2341 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1882 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 510 | 0.090 |
Why?
|
| Adolescent | 2 | 2020 | 9341 | 0.090 |
Why?
|
| Genomics | 1 | 2015 | 784 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1991 | 0.080 |
Why?
|
| Risk Factors | 1 | 2019 | 5578 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 857 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6808 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2016 | 2335 | 0.080 |
Why?
|
| Prognosis | 1 | 2016 | 3810 | 0.080 |
Why?
|
| Young Adult | 1 | 2019 | 6412 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2017 | 3426 | 0.070 |
Why?
|
| United States | 1 | 2019 | 7138 | 0.070 |
Why?
|
| Mice | 4 | 2021 | 11932 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2407 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3273 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 27690 | 0.050 |
Why?
|
| Injections, Intralesional | 1 | 2021 | 22 | 0.050 |
Why?
|
| TRPA1 Cation Channel | 1 | 2021 | 1 | 0.050 |
Why?
|
| Leukotrienes | 1 | 2021 | 20 | 0.050 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2020 | 6 | 0.050 |
Why?
|
| Scalp | 1 | 2021 | 72 | 0.050 |
Why?
|
| Mast Cells | 1 | 2021 | 94 | 0.050 |
Why?
|
| Histamine | 1 | 2021 | 126 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 145 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 183 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 359 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 854 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 277 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2017 | 38 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 75 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 1192 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2017 | 129 | 0.030 |
Why?
|
| Polytene Chromosomes | 1 | 2015 | 1 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2015 | 24 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 990 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 71 | 0.030 |
Why?
|
| Codon | 1 | 2015 | 123 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 135 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 175 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 703 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 2467 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 177 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 302 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 453 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 690 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2033 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 5364 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 552 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2015 | 517 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 614 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 8367 | 0.020 |
Why?
|